CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLL
Published: | Updated:
The treatment landscape for chronic lymphocytic leukemia has dramatically changed in the past decade.
Charalambos Andreadis, MD, MSCE
Advertisement
Articles by Charalambos Andreadis, MD, MSCE
Advertisement
Latest Updated Articles
CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLLPublished: November 14th 2019 | Updated: November 11th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Accelerated Approval to Zongertinib in HER2+ NSCLC
2
Iza-Bren Yields Statistically Significant Efficacy in Advanced TNBC
3
Decoding Key Community Oncology Takeaways From ASCO GI 2026
4
Olaparib Combo Improves PFS/OS in BRCA+ or ATM+ Metastatic CRPC
5